| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.62 | 0.0003 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.5 | 0.001 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.37 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.29 | 0.03 |